Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Stoke Therapeutics Inc buy Needham & Company LLC

Start price
€4.46
07.11.23 / 50%
Target price
€13.09
07.11.24
Performance (%)
67.04%
Price
€7.45
28.02.24
Summary
This prediction is currently active. The BUY prediction by Needham___Company_LL for Stoke Therapeutics Inc has seen massive gains of 67.04%. This prediction currently runs until 07.11.24. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Stoke Therapeutics Inc 52.664% 52.664%
iShares Core DAX® 2.635% 3.881%
iShares Nasdaq 100 2.074% 2.844%
iShares Nikkei 225® 0.846% 6.239%
iShares S&P 500 1.587% 3.955%

Comments by Needham___Company_LL for this prediction

In the thread Stoke Therapeutics Inc diskutieren
Prediction Buy
Perf. (%) 67.04%
Target price 13.086
Change
Ends at 07.11.24

Stoke Therapeutics, Inc. (NASDAQ: STOK) had its price target lowered by analysts at Needham & Company LLC from $25.00 to $14.00. They now have a "buy" rating on the stock.
Ratings data for STOK provided by MarketBeat

Stopped prediction by Needham___Company_LL for Stoke Therapeutics Inc

buy
Stoke Therapeutics Inc

Start price
Target price
Perf. (%)
€4.86
16.02.24
€13.02
16.02.25
52.26%
28.02.24

buy
Stoke Therapeutics Inc

Start price
Target price
Perf. (%)
€5.20
07.08.23
€22.72
07.08.24
43.27%
28.02.24

buy
Stoke Therapeutics Inc

Start price
Target price
Perf. (%)
€8.60
08.03.23
€23.71
08.03.24
-13.95%
28.02.24